Bicycle Therapeutics Plc Stock price
Is Bicycle Therapeutics Plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,102 stocks worldwide.
Key metrics
Bicycle Therapeutics Plc Stock Analysis
Analyst Opinions
16 Analysts have issued a Bicycle Therapeutics Plc forecast:
Analyst Opinions
16 Analysts have issued a Bicycle Therapeutics Plc forecast:
Bicycle Therapeutics Plc Events
Upcoming Event
Don't miss a Thing! We will send you all news about Bicycle Therapeutics Plc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Bicycle Therapeutics Plc Stock News
Company Profile
Bicycle Therapeutics Plc is a holding company, which engages in the development of biopharmaceuticals. It focuses on developing a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. The firm utilizes its novel and proprietary phage display screening platform to identify bicycles. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
| Head office | United Kingdom |
| CEO | Dr. Lee |
| Employees | 288 |
| Founded | 2009 |
| Website | www.bicycletherapeutics.com |


